Compare TTK HEALTHCARE with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ASTRAZENECA PHARMA TTK HEALTHCARE/
ASTRAZENECA PHARMA
 
P/E (TTM) x 17.8 72.5 24.6% View Chart
P/BV x 1.4 20.4 7.0% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 TTK HEALTHCARE   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
ASTRAZENECA PHARMA
Mar-18
TTK HEALTHCARE/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2151,278 95.1%   
Low Rs610883 69.1%   
Sales per share (Unadj.) Rs444.4228.4 194.6%  
Earnings per share (Unadj.) Rs17.210.4 166.4%  
Cash flow per share (Unadj.) Rs27.616.3 169.9%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.998.8 180.2%  
Shares outstanding (eoy) m14.1325.00 56.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.14.7 43.4%   
Avg P/E ratio x52.9104.2 50.8%  
P/CF ratio (eoy) x33.066.4 49.7%  
Price / Book Value ratio x5.110.9 46.9%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,89427,008 47.7%   
No. of employees `0002.31.4 170.5%   
Total wages/salary Rs m1,3071,535 85.1%   
Avg. sales/employee Rs Th2,715.74,210.9 64.5%   
Avg. wages/employee Rs Th565.31,132.2 49.9%   
Avg. net profit/employee Rs Th105.4191.1 55.2%   
INCOME DATA
Net Sales Rs m6,2795,710 110.0%  
Other income Rs m78123 63.3%   
Total revenues Rs m6,3565,833 109.0%   
Gross profit Rs m496463 107.1%  
Depreciation Rs m147147 99.5%   
Interest Rs m340-   
Profit before tax Rs m393438 89.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m149179 83.2%   
Profit after tax Rs m244259 94.1%  
Gross profit margin %7.98.1 97.4%  
Effective tax rate %37.940.8 92.9%   
Net profit margin %3.94.5 85.5%  
BALANCE SHEET DATA
Current assets Rs m2,7173,209 84.7%   
Current liabilities Rs m1,5712,070 75.9%   
Net working cap to sales %18.320.0 91.5%  
Current ratio x1.71.6 111.5%  
Inventory Days Days3272 44.5%  
Debtors Days Days4735 133.6%  
Net fixed assets Rs m991790 125.4%   
Share capital Rs m14150 282.6%   
"Free" reserves Rs m2,3732,419 98.1%   
Net worth Rs m2,5142,469 101.8%   
Long term debt Rs m30-   
Total assets Rs m4,1584,605 90.3%  
Interest coverage x12.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.51.2 121.8%   
Return on assets %6.75.6 118.6%  
Return on equity %9.710.5 92.4%  
Return on capital %16.917.7 95.5%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m225300 75.2%   
Fx outflow Rs m712,015 3.5%   
Net fx Rs m154-1,715 -9.0%   
CASH FLOW
From Operations Rs m17388 196.9%  
From Investments Rs m97-94 -103.1%  
From Financial Activity Rs m-307NA-  
Net Cashflow Rs m-38-6 661.4%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 0.3 1,233.3%  
FIIs % 5.2 15.7 33.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 9.1 283.5%  
Shareholders   12,723 12,856 99.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 19, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS